Glioblastoma News and Research

RSS
Glioblastoma is the most aggressive and malignant form of glioma, a type of primary brain cancer. Surgery is often used to treat gliomas, along with radiation. However, since surgery and radiation fail to cure the disease, doctors may turn to additional radiation or chemotherapy. In early stages glioblastoma tumors often grow without symptoms and therefore can become quite large before symptoms arise. When the tumor becomes symptomatic, tumor growth is usually very rapid and is accompanied by altered brain function, and if left untreated the disease becomes lethal. Although primary treatment is often successful in temporarily stopping the progression of the tumor, glioblastomas almost always recur and become lethal.
"Goldilocks" balance holds key to awakening the body's immune response to combat brain cancer

"Goldilocks" balance holds key to awakening the body's immune response to combat brain cancer

New anticancer molecule shows therapeutic activity in preclinical models of various cancer types

New anticancer molecule shows therapeutic activity in preclinical models of various cancer types

Study may lead to new therapeutic methods for treating aggressive brain cancer

Study may lead to new therapeutic methods for treating aggressive brain cancer

Discovery of neoantigens could widen the possibilities for universal cancer vaccine

Discovery of neoantigens could widen the possibilities for universal cancer vaccine

UC experts explore if ketogenic diet could help make treatments for glioblastoma

UC experts explore if ketogenic diet could help make treatments for glioblastoma

New imaging technology may help surgeons better detect cancer during surgery

New imaging technology may help surgeons better detect cancer during surgery

Healthy neurons form surprising connections with aggressive brain cancer cells

Healthy neurons form surprising connections with aggressive brain cancer cells

Children's of Alabama using cold sore virus to fight pediatric brain cancer

Children's of Alabama using cold sore virus to fight pediatric brain cancer

New finding could become glioblastoma’s Achilles heel

New finding could become glioblastoma’s Achilles heel

Leukemia drug appears to be effective in treating deadly pediatric brain tumor

Leukemia drug appears to be effective in treating deadly pediatric brain tumor

Researchers describe how neurons establish contact with aggressive glioblastomas, promote tumor growth

Researchers describe how neurons establish contact with aggressive glioblastomas, promote tumor growth

Brain tumors hijack healthy neurons in order to grow

Brain tumors hijack healthy neurons in order to grow

Insulin drug could treat glioblastoma

Insulin drug could treat glioblastoma

Existing drug could be used to treat glioblastoma

Existing drug could be used to treat glioblastoma

A factor that predicts prolonged survival in brain tumor uncovered

A factor that predicts prolonged survival in brain tumor uncovered

Study gives insight into how immunotherapies may be delivered directly to brain tumors

Study gives insight into how immunotherapies may be delivered directly to brain tumors

UTA receives CPRIT funding to support cancer research programs

UTA receives CPRIT funding to support cancer research programs

Scientists discover potential novel target for treating deadly brain cancer

Scientists discover potential novel target for treating deadly brain cancer

Study opens up a new way for developing potential glioblastoma treatment

Study opens up a new way for developing potential glioblastoma treatment

Research explains why many psychiatric drugs that work in the lab don’t work in people

Research explains why many psychiatric drugs that work in the lab don’t work in people

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.